Alivus Life

67
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
1,368.05
-15.2 (-1.1%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 43.65 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 6.91% vs 4.54% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 16.80% vs 1.24% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 122.54% vs 56.14% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 16.24% vs 3.13% in Mar 2025

Compare Profit and Loss Results of Alivus Life
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,551.00
263.00
2,288.00
869.96%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,551.00
263.00
2,288.00
869.96%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
0.00
3.00
0%
Raw Materials Consumed
1,063.00
0.00
1,063.00
0%
Power & Fuel Cost
113.00
26.00
87.00
334.62%
Employee Cost
272.00
103.00
169.00
164.08%
Operating Expenses
173.00
25.00
148.00
592.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
56.00
1.00
55.00
5,500.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
39.00
3.00
36.00
1,200.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,754.00
214.00
1,540.00
719.63%
Operating Profit (PBDIT) excl Other Income
797.00
48.00
749.00
1,560.42%
Other Income
60.00
2.00
58.00
2,900.00%
Operating Profit (PBDIT)
857.00
51.00
806.00
1,580.39%
Interest
5.00
7.00
-2.00
-28.57%
Profit before Depriciation and Tax
852.00
43.00
809.00
1,881.40%
Depreciation
75.00
6.00
69.00
1,150.00%
Profit Before Taxation & Exceptional Items
776.00
37.00
739.00
1,997.30%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
751.00
29.00
722.00
2,489.66%
Provision for Tax
186.00
9.00
177.00
1,966.67%
Profit After Tax
564.00
19.00
545.00
2,868.42%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,777.00
1,018.00
759.00
74.56%
Profit Available for appropriations
2,341.00
1,038.00
1,303.00
125.53%
Appropriations
2,341.00
1,038.00
1,303.00
125.53%
Equity Dividend (%)
250%
500%
-250.00
Earnings Per Share
45.99
3.97
42.02
1,058.44%
Profit And Loss - Net Sales
Net Sales 2,551.83 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 6.91% vs 4.54% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 797.28 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.80% vs 1.24% in Mar 2025

Profit And Loss - Interest
Interest 5.37 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 122.54% vs 56.14% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 564.48 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.24% vs 3.13% in Mar 2025

Footer loading